Fibrinogen is an independent preoperative predictor of hospital length of stay among patients undergoing coronary artery bypass grafting
暂无分享,去创建一个
[1] Guowei Zhao,et al. Blood fibrinogen level as a biomarker of adverse outcomes in patients with coronary artery disease: A systematic review and meta-analysis , 2022, Medicine.
[2] W. Rief,et al. IL-8 and CRP moderate the effects of preoperative psychological interventions on postoperative long-term outcomes 6 months after CABG surgery – The randomized controlled PSY-HEART trial , 2020, Brain, Behavior, and Immunity.
[3] J. Cleveland,et al. Stage 1 acute kidney injury is independently associated with infection following cardiac surgery. , 2019, The Journal of thoracic and cardiovascular surgery.
[4] T. Lüscher,et al. Coronary artery bypass confers intermediate-term survival benefit over percutaneous coronary intervention with new-generation stents in real-world patients with multivessel coronary artery disease, including left main disease: a retrospective analysis of 6383 patients. , 2019, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[5] M. AbuRuz. Pre-operative depression predicted longer hospital length of stay among patients undergoing coronary artery bypass graft surgery , 2019, Risk management and healthcare policy.
[6] M. AbuRuz,et al. Checking the moderating effect of perceived control on the relationship between anxiety and postoperative hospital length of stay among coronary artery bypass graft patients , 2019, International journal of general medicine.
[7] G. Moukarbel,et al. Pre-operative right ventricular echocardiographic parameters associated with short-term outcomes and long-term mortality after CABG , 2018, Echo research and practice.
[8] K. Näntö-Salonen,et al. Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment , 2018, Haemophilia : the official journal of the World Federation of Hemophilia.
[9] Panos Vardas,et al. European Society of Cardiology: Cardiovascular Disease Statistics 2017. , 2018, European heart journal.
[10] B. Sharif-Kashani,et al. Prophylactic Fibrinogen Decreases Postoperative Bleeding but Not Acute Kidney Injury in Patients Undergoing Heart Transplantation , 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[11] A. Kulik. Quality of life after coronary artery bypass graft surgery versus percutaneous coronary intervention: what do the trials tell us? , 2017, Current opinion in cardiology.
[12] R. Bellomo,et al. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment , 2017, Nature Reviews Nephrology.
[13] A. Nierich,et al. Effect of Fibrinogen Concentrate on Intraoperative Blood Loss Among Patients With Intraoperative Bleeding During High-Risk Cardiac Surgery: A Randomized Clinical Trial , 2017, JAMA.
[14] C. Jackson,et al. Inflammation in Chronic Wounds , 2016, International journal of molecular sciences.
[15] P. Aylin,et al. Factors associated with prolonged length of stay following cardiac surgery in a major referral hospital in Oman: a retrospective observational study , 2016, BMJ Open.
[16] E. Tremoli,et al. Biomarkers in Coronary Artery Bypass Surgery: Ready for Prime Time and Outcome Prediction? , 2016, Front. Cardiovasc. Med..
[17] M. Duran,et al. Elevated serum fibrinogen levels and risk of contrast-induced acute kidney injury in patients undergoing a percutaneous coronary intervention for the treatment of acute coronary syndrome , 2016, Coronary artery disease.
[18] M. Jahangiri,et al. Health-related personal control predicts depression symptoms and quality of life but not health behaviour following coronary artery bypass graft surgery , 2015, Journal of Behavioral Medicine.
[19] M. Jahangiri,et al. Optimism measured pre-operatively is associated with reduced pain intensity and physical symptom reporting after coronary artery bypass graft surgery , 2014, Journal of psychosomatic research.
[20] M. Jahangiri,et al. Attachment anxiety predicts IL-6 and length of hospital stay in coronary artery bypass graft surgery (CABG) patients , 2014, Journal of psychosomatic research.
[21] M. Jahangiri,et al. Depression, C-reactive protein and length of post-operative hospital stay in coronary artery bypass graft surgery patients , 2014, Brain, Behavior, and Immunity.
[22] M. Jahangiri,et al. The combined association of depression and socioeconomic status with length of post-operative hospital stay following coronary artery bypass graft surgery: Data from a prospective cohort study☆ , 2014, Journal of psychosomatic research.
[23] J. Dowd,et al. Fibrinogen may mediate the association between long sleep duration and coronary heart disease , 2013, Journal of sleep research.
[24] Ronald P. Brown,et al. Fibrinogen excretion in the urine and immunoreactivity in the kidney serves as a translational biomarker for acute kidney injury. , 2012, The American journal of pathology.
[25] A. Street,et al. Why do patients having coronary artery bypass grafts have different costs or length of stay? An analysis across 10 European countries. , 2012, Health economics.
[26] Howard K. Song,et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. , 2011, The Annals of thoracic surgery.
[27] Howard K. Song,et al. Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines , 2011 .
[28] Shengshou Hu,et al. Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery. , 2010, The Annals of thoracic surgery.
[29] G. Lip,et al. Fibrinogen: biochemistry, epidemiology and determinants. , 2003, QJM : monthly journal of the Association of Physicians.
[30] Demosthenes B. Panagiotakos,et al. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002) , 2003, Current medical research and opinion.
[31] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..